Insights into Hepatobiliary Neoplasia

Description

Presenters in this session will share their research into novel techniques to understand hepatobiliary neoplasia, including the interaction of known carcinnogenic stimuli and the immune system.

Journey Maps

Presentations

8:00 AM - 8:15 AM
Aug 06 2026
Convention Center - Ballroom C, Level 3

Single-cell Transcriptional Profiling of Chronic Woodchuck Hepatitis-induced Hepatocellular Carcinoma Reveals a Proliferative Tumor Subtype and Tumor-driven Immune Exhaustion Shared with Human HCC

Daniela Sia, PhD , Abstract Presenter
Liver Cancer
8:15 AM - 8:30 AM
Aug 06 2026
Convention Center - Ballroom C, Level 3

Development of Gene-Edited T Cell Therapy Targeting TERT in Hepatocellular Carcinoma

Sumera I. Ilyas, MD , Abstract Presenter
Liver Cancer
8:30 AM - 8:45 AM
Aug 06 2026
Convention Center - Ballroom C, Level 3

Liver Zonation Breakdown Fuels Hepatocellular Carcinoma in Chronic Liver Disease

Daniela Sia, PhD , Abstract Presenter
Liver Cancer
8:45 AM - 9:00 AM
Aug 06 2026
Convention Center - Ballroom C, Level 3

Photothermally modulated liposome enabling efficient release of 2-deoxy-D-glucose safely displays vigorous antitumor effect against liver cancer

Sumera I. Ilyas, MD , Abstract Presenter
Liver Cancer
9:00 AM - 9:15 AM
Aug 06 2026
Convention Center - Ballroom C, Level 3

PD-L1(+) Macrophages Activated by Tumor-Derived GM-CSF Induce CD8(+) T Cell Exhaustion in Hepatocellular Carcinoma

Daniela Sia, PhD , Abstract Presenter
Liver Cancer
9:15 AM - 9:30 AM
Aug 06 2026
Convention Center - Ballroom C, Level 3

SIRPα knockout in T cells inhabits immune evasion of hepatocellular carcinoma

Sumera I. Ilyas, MD , Abstract Presenter
Liver Cancer

Objectives

  • Describe cutting-edge techniques for studying hepatocarcinogenesis
  • Recognize structural-functional links in hepatocarcinogenesis
  • Evaluate the role of immune cells in hepatocarcinogenesis